Mechanistic Investigation of Xuebijing for Treatment of Paraquat-Induced Pulmonary Fibrosis by Metabolomics and Network Pharmacology.

Wang, Tongtong; Li, Sha; Wu, Yangke; Yan, Xiao; Zhu, Yiming; Jiang, Yu; Jiang, Feiya; Liu, Wen

Wang, Tongtong; Li, Sha; Wu, Yangke; Yan, Xiao; Zhu, Yiming; Jiang, Yu; Jiang, Feiya; Liu, Wen.

Afiliação

Wang T; Department of Pharmacy, The First Affiliate Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.
Li S; Department of Pharmacy, Changsha Stomatological Hospital, Changsha 410005, China.
Wu Y; Department of Pharmacy, The First Affiliate Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.
Yan X; Department of Pharmacy, The First Affiliate Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.
Zhu Y; Department of Pharmacy, The First Affiliate Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.
Jiang Y; Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Changsha 410005, China.
Jiang F; Department of Pharmacy, The First Affiliate Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.
Liu W; Department of Pharmacy, The First Affiliate Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.

ACS Omega ; 6(30): 19717-19730, 2021 Aug 03.

Article em En | MEDLINE | ID: mdl-34368559

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Omega Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google